Returning to high prestige BIO Asia -Taiwan Expo

Prata di Pordenone, Italy: – Leading pharma process equipment supplier LAST Technology will again be a prominent presence at the upcoming BIO Asia – Taiwan International Conference and Exhibition in Taipei.

This will be LAST Technology’s second successive appearance at the annual event, providing a further opportunity to showcase its advanced and highly tailored cGMP and cGLP process solutions to the increasingly important Taiwanese pharma and biotech sector.

LAST Technology will exhibit from Booth L610 in the huge TaiNEX exhibition center, in collaboration with its regional agent. The stand team will be led by Sebastiano Avesani, LAST Technology Sales Manager for the Asia-Pacific (APAC) Region.

Advanced cGMP and cGLP  solution

LAST Technology will again capitalize on this high-prestige event that brings together bioindustry executives and investors from North America, Europe, and Asia as an opportunity to explore business opportunities and engage with Taiwan’s emerging biotech sector.

BIO Asia – Taiwan provides a great opportunity for Asian pharma and biotech producers to meet o meet the LAST Technology team and discover more about the technically advanced process equipment range that includes sterilizing solutions as well as washing solutions designed and built to meet each client’s specific needs.

Examples of LAST Technology product sophistication relevant to Asian producers include its UCW series glassware and component washers that offer exceptionally compact and powerful solutions for GMP-compliant pharmaceutical and biotech environments, with fully automated cycles, along with HEPA hot-air drying and continuous monitoring of key parameters, such as conductivity and pH.

About LAST Technology

Founded in 2012 and based in far northeastern Italy, LAST Technology s.r.l. has taken little more than a decade to establish itself as a leading provider of highly advanced and cost-effective process equipment for the pharma, biotech, medical research, and other industries.

LAST Technology specializes in highly tailored end-to-end washing, disinfection, sterilization, depyrogenation, decontamination, and containment solutions adapted to individual customer needs, with tailored machines whose design recognizes all aspects of the product life cycle, from prototype to product launch and validation.

Its Lab Division specializes in providing cGLP process equipment for research and microbiological laboratories, including washing, decontamination, disinfection and sterilization equipment, while Pharma Division focuses on cGMP process machinery for pharmaceutical and biotechnology manufacturing, including UCW machines for washing, disinfection and drying, RSA Autoclaves, TS-AS and TS-OW Terminal Sterilizers, DHS Dry Heat Sterilizers, DPB Decontamination Pass Box equipment, and CPE and CPE-W Closure Processing Equipment for end-to-end container processing.

LAST solutions are given added value by high levels of quality, reliability and sustainability, reflected in design for reduced energy consumption and footprint, engineering based on easily obtainable commercial components, integration with Industry 4.0 Manufacturing Execution System (MES) principles, extensive GMP and GAMP5 documentation, FDA 21 CFR, Part 11 data integrity, and extensive technical support.

Learn more at: https://lasttechnology.it/en/

About BIO Asia-Taiwan 2025

First hosted n 2019, the annual BIO Asia-Taiwan International Conference & Exhibition, recognizes Asia as a region of growing importance within the global pharma industry, and celebrates Taiwan’s standing as a leading biotechnology hub.

With the introduction of two Demo Day featuring site visits to major biomedical parks and presentations from Taiwan’s biotech startups, BIO Asia–Taiwan 2025 has become a five-day event opening July 23, 2025, at the Taipei Nangang Exhibition Center (TaiNEX), where two halls will accommodate nearly 900 exhibitors with more than 2,200 booths.

The 2025 conference is themed “Next Wave of Biotech Opportunities”, underlining the transformative role of Asian biotech in global innovation and public health and is expected to attract more than 2,200 visitors.

The event is jointly organized by the Biotechnology Innovation Organization as an extension of its established BIO event franchise, in collaboration with the Taiwan Bio Industry Organization (Taiwan BIO) and Chan Chao International Co., with further information at https://bioasiataiwan.com/

Resources

Click on Visit LAST Technology at BIO Asia – Taiwan a 2025 for further details.